Skip to content

Drug interactions

Hepatitis a / b vaccine + Ocrelizumab

Severity: Moderate

Hepatitis a / b vaccine and Ocrelizumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ocrelizumab-induced B-cell depletion blunts antibody responses to inactivated vaccines, so protection from the hepatitis A/B vaccine may be inadequate. The vaccine is not unsafe, but its effectiveness is reduced.

What this interaction means in plain words

Hepatitis a / b vaccine and Ocrelizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Depletion of CD20-positive B cells impairs humoral immune responses to vaccine antigens.

What to do

Complete vaccination at least 2 weeks before starting ocrelizumab where feasible. If given during treatment, check serology afterward and revaccinate as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Hepatitis a / b vaccine and Ocrelizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Hepatitis a / b vaccine with Ocrelizumab?

MediHelp rates the interaction as moderate. Hepatitis a / b vaccine and Ocrelizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ocrelizumab-induced B-cell depletion blunts antibody responses to inactivated vaccines, so protection from the hepatitis A/B vaccine may be inadequate. The vaccine is not unsafe, but its effectiveness is reduced.

How serious is the interaction between Hepatitis a / b vaccine and Ocrelizumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Complete vaccination at least 2 weeks before starting ocrelizumab where feasible. If given during treatment, check serology afterward and revaccinate as needed.

What other medicines interact with Ocrelizumab?

MediHelp also lists interactions of Ocrelizumab with, for example, Adenovirus types 4 and 7 live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Ocrelizumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in